Abstract:Small cell carcinoma of the esophagus (SCCE) is a rare but highly aggressive neuroendocrine carcinoma. Despite aggressive initial therapy, most patients with SCCE suffer a rapid recurrence and die within a few months. Given the great success of cancer immunotherapy targeting the PD-1/PD-L1 pathway, we sought to assess the expression pattern and clinical significance of PD-L1 in previously untreated SCCE for the first time. Formalin-fixed paraffin-embedded whole tumor sections were obtained from 147 patients with SCCE underwent surgery at our institution between 1985 and 2019. PD-L1 expression was evaluated by immunohistochemistry (clone E1L3N) in both tumor cells (TCs) and tumor-infiltrating immune cells (ICs). PD-L1 positivity (PD-L1+) was defined as ≥1% TCs with circumferential or partial membranous staining, or ICs with membranous or cytoplasmic staining. A combined positive score (CPS) of PD-L1 expression was also calculated and CPS ≥1 was considered positive. Baseline clinicopathological characteristics and outcome data [relapse free survival (RFS) and overall survival (OS)] were correlated with PD-L1 staining. None of the 147 patients was considered PD-L1+ in TCs and PD-L1+ in ICs was observed in 65 (44.2%) patients. Forty-two (28.6%) patients showed CPS positivity. PD-L1+ in ICs was significantly associated with shorter tumor length (P=0.003), macroscopic tumor type (P=0.011), and lower T stage (P=0.028), as well as increased RFS (P=0.0099) and OS (P=0.0005). PD-L1+ by CPS was also found significantly correlated with shorter tumor length (P=0.014), macroscopic tumor type (P=0.015), and lower T stage (P<0.001), as well as better OS (P=0.0453). Whereas, only a trend toward longer RFS (P=0.0671) was observed in patients with CPS positivity. Here, for the first time, we showed that approximately half of the SCCEs express PD-L1 and all the expression is observed in immune cells. Patients with PD-L1 expression are associated with early stage and better survival. These data provide a rational basis for further investigation of PD-L1/PD-1-based immunotherapy for patients with SCCE.

Primary Small Cell Carcinoma of the Esophagus: Progression in the Last Decade

A Retrospective Study of Different Treatments of Limited-Stage Small-Cell Esophageal Carcinoma and Associated Prognostic Factor Analysis

Primary small cell carcinoma of the esophagus: Retropective analysis of the Veterans Affairs Cancer Registry.

Primary Squamous Cell Carcinoma of the Esophagus Initially Presenting As A Large Retroperitoneal Mass: A Case Diagnosed As Cancer of Unknown Primary Site

Successful Outcome of Neoadjuvant PD-1 Blockade, VEGFR-2 Inhibitor Plus Chemotherapy for Potentially Unresectable Esophagogastric Junctional Squamous Cell Carcinoma: a Case Report

A 10-Year Population-Based Study of the Differences Between NECs and Carcinomas of the Esophagus.

Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes

Primary Small Cell Carcinoma of the Esophagus: Clinicopathological Study of 44 Cases.

1176P Expression and clinical significance of PD-L1 in small cell carcinoma of the esophagus

Detailed Analysis of Prognostic Factors in Primary Esophageal Small Cell Carcinoma

Diagnosis and Treatment of Primary Pulmonary Enteric Adenocarcinoma: Report of Six Cases

Pulmonary sarcomatoid carcinoma: progress, treatment and expectations

Retrospective Analysis of 20 Cases of Primary Esophageal Small Cell Carcinoma

Epigastric Pain and Dysphagia in a 36-Year-Old Man Due to Primary Esophageal Small Cell Carcinoma

Clinical analysis of 32 cases of esophageal small cell carcinoma

Small cell carcinoma esophagus-A tertiary cancer center experience of a rare variant

A Young Man with Progressive Esophageal Neoplasms.

Locally Advanced Anal Small Cell Carcinoma with Durable Complete Response to Chemoradiation Followed by Consolidation Chemotherapy: Case Report and Literature Review.

Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration

Primary malignant melanoma of the esophagus: A case report and review of the literature

Primary Malignant Melanoma of the Esophagus: a Population-Based Study